This inventor holds 2 USPTO granted patents. Top assignee: Madera Therapeutics, LLC. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Edwin Iwanowicz: Innovator in Biomarker Research
Introduction
Edwin Iwanowicz is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of biomarker research, particularly in relation to cancer treatment. His innovative work focuses on the use of caseinolytic protease P as a predictive biomarker for drug response.
Latest Patents
Iwanowicz holds a patent titled "Use of caseinolytic protease P function as a biomarker of drug response to imipridone-like agents." This patent describes the use of ClpP function and/or concentration as a biomarker for predicting the response of neoplastic diseases, especially cancer. The patent also outlines methods and kits for treatment involving this biomarker.
Career Highlights
Edwin Iwanowicz is currently associated with Madera Therapeutics, LLC, where he continues to advance his research in biomarker applications. His work is pivotal in enhancing therapeutic benefits for patients with neoplastic diseases.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Edwin Iwanowicz's contributions to biomarker research exemplify the innovative spirit of modern science. His work has the potential to significantly impact cancer treatment and improve patient outcomes.